The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
MJFF Research Grant, 2009Supplemental Biomarkers Study to Clinical Trial for CoQ10
Objective/Rationale:
There is a critical need for biomarkers of Parkinson’s disease (PD), for accurate and earlier diagnosis, and for monitoring treatment effects. We are investigating two potential... -
MJFF Research Grant, 2009Assessing Heart Rate Variability (HRV) in the Parkinson's Associated Risk Study (PARS) Cohort
Objective/Rationale:
The objective of this study is to determine if HRV, which is reduced in PD, is significantly reduced in subjects with hyposmia (loss of smell) compared to subjects who are... -
Rapid Response Innovation Awards, 2009Validating the Electrocardiogram as a Tool to Identify Pre-motor Parkinson's Disease
Promising Outcomes of Original Grant:
Our goal in the funded RRIA was to determine if a 5 minute EKG recordings in patients with a high probably of having pre-motor PD, i.e., individuals with... -
Research Grant, 2009Biomarkers of Pioglitazone Effects in Parkinson's Disease (BioPEP)
Objective/Rationale:
Pioglitazone is a medication used to treat diabetes that that has shown promise in laboratory studies for potentially slowing the progression of Parkinson’s disease (PD). The... -
Rapid Response Innovation Awards, 2009Glycine Uptake Inhibitors as Potential Enhancers of Dopaminergic Axon Regeneration
Objective/Rationale
An important goal in Parkinson’s disease therapy is to restore the loss of the dopaminergic innervation of the striatum. Cell culture data from our lab indicate that activation of... -
Rapid Response Innovation Awards, 2009Multi-site Coordinated Reset Stimulation of the Subthalamic Nucleus
Objective/Rationale:
Current deep brain stimulation (DBS) does not take advantage of the latest discoveries of Parkinson’s disease (PD) pathophysiology which may explain some of its limitations...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.